My laboratory research focuses on two intersecting areas:
1) Molecular progression of breast and prostate cancers to aggressive phenotype,
2) Nanotechnology approaches for targeted therapeutics. In one of our studies, we are determining the role of exosomal annexin A2 in metastatic progression of breast and prostate cancers. In another project, we are studying how MIEN1 (a protein that was discovered in our lab) promotes migration and invasion of cancer cells leading to metastatic progression. We are also utilizing novel targeted nanodevices for treatment of bone metastatic prostate cancer and for metastatic triple negative breast cancer.